Abstract:OBJECTIVES:Heme oxygenase-1 is inducible in cardiomyocytes in response to stimuli such as oxidative stress and plays critical roles in combating cardiac hypertrophy and injury. Signal transducer and activator of transcription 3 plays a pivotal role in heme oxygenase-1-mediated protection against liver and lung injuries under oxidative stress. We hypothesized that propofol, an anesthetic with antioxidant capacity, may attenuate hyperglycemia-induced oxidative stress in cardiomyocytes via enhancing heme oxygenase-1 activation and ameliorate hyperglycemia-induced cardiac hypertrophy and apoptosis via heme oxygenase-1/signal transducer and activator of transcription 3 signaling and improve cardiac function in diabetes. DESIGN:Treatment study. SETTING:Research laboratory. SUBJECTS:Sprague-Dawley rats. INTERVENTIONS:In vivo and in vitro treatments. MEASUREMENTS AND MAIN RESULTS:At 8 weeks of streptozotocin-induced type 1 diabetes in rats, myocardial 15-F2t-isoprostane was significantly increased, accompanied by cardiomyocyte hypertrophy and apoptosis and impaired left ventricular function that was coincident with reduced heme oxygenase-1 activity and signal transducer and activator of transcription 3 activation despite an increase in heme oxygenase-1 protein expression as compared to control. Propofol infusion (900 μg/kg/min) for 45 minutes significantly improved cardiac function with concomitantly enhanced heme oxygenase-1 activity and signal transducer and activator of transcription activation. Similar to the changes seen in diabetic rat hearts, high glucose (25 mmol/L) exposure for 48 hours led to cardiomyocyte hypertrophy and apoptosis, both in primary cultured neonatal rat cardiomyocytes and in H9c2 cells compared to normal glucose (5.5 mmol/L). Hypertrophy was accompanied by increased reactive oxygen species and malondialdehyde production and caspase-3 activity. Propofol, similar to the heme oxygenase-1 inducer cobalt protoporphyrin, significantly increased cardiomyocyte heme oxygenase-1 and p-signal transducer and activator of transcription protein expression and heme oxygenase-1 activity and attenuated high-glucose-mediated cardiomyocyte hypertrophy and apoptosis and reduced reactive oxygen species and malondialdehyde production (p < 0.05). These protective effects of propofol were abolished by heme oxygenase-1 inhibition with zinc protoporphyrin and by heme oxygenase-1 or signal transducer and activator of transcription 3 gene knockdown. CONCLUSIONS:Heme oxygenase-1/signal transducer and activator of transcription 3 signaling plays a critical role in propofol-mediated amelioration of hyperglycemia-induced cardiomyocyte hypertrophy and apoptosis, whereby propofol improves cardiac function in diabetic rats.

Protective Effect of Propofol Against H 2O 2 Potentiated TNF-alpha Induced Human Vascular Endothelial Cell Apoptosis

Effects of Propofol in TNF-induced Apoptosis in Endothelial Cells Derived from Human Umbilical Vein

[Resveratrol Protects Against Hydrogen Peroxide Induced Injury in Human Umbilical Vein Endothelial Cells].

Propofol Dose-Dependently Reduces Tumor Necrosis Factor-Alpha-Induced Human Umbilical Vein Endothelial Cell Apoptosis: Effects on Bcl-2 and Bax Expression and Nitric Oxide Generation

Propofol Inhibited the Apoptosis of Human Hepatic L02 Cells Induced by H2O2

Propofol and nitric oxide in TNF-alpha induced human ECV304 apoptosis

Effects of Propofol in Apoptosis Related Genes Expression on Cultured Human Umbilical Vein Endothelial Cells

Antioxidative And Anti-Endotoxin Effects Of Propofol On Endothelial Cells

The protective effect of propofol against TNF-α-induced apoptosis was mediated via inhibiting iNOS/NO production and maintaining intracellular Ca 2+ homeostasis in mouse hippocampal HT22 cells.

Propofol protects hepatic L02 cells from hydrogen peroxide-induced apoptosis via activation of extracellular signal-regulated kinases pathway.

Propofol Upregulates Heme Oxygenase-1 Through Activation of ERKs in Human Umbilical Vein Endothelial Cells under Oxidative Stress Conditions

Propofol Attenuates Oxidative Stress-Induced Pc12 Cell Injury Via P38 Map Kinase Dependent Pathway

Propofol Protects Against H2O2-Induced Oxidative Injury in Differentiated PC12 Cells Via Inhibition of Ca2+-Dependent NADPH Oxidase

Propofol Attenuates H2O2-induced Oxidative Stress and Apoptosis Via the Mitochondria- and ER-medicated Pathways in Neonatal Rat Cardiomyocytes.

Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats.

Protective Effect of Propofol on Hydrogen Peroxide-Induced Human Esophageal Carcinoma Via Blocking the Wnt/β-catenin Signaling Pathway

Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats.

Effects of Propofol on the Changes in Cytoskeleton and Cellular Permeability of Human Umbilical Vascular Endothelial Cells Monolayer Induced by Lipopolysaccharide

Propofol Protects Against TNF-α-induced Blood-brain Barrier Disruption via the PIM-1/eNOS/NO Pathway

Protective Effect of Propofol Preconditioning on PC12 Cells Injury Induced by Lethal Heat

Nitroglycerin Reduces TNF‐α Toxicity to Endothelial Cells but Compromises the Protective Effects of Propofol